Glucotrack (GCTK) announced the pricing of a “best efforts” public offering of approximately 2.6M shares of common stock. The offering price of each share of common stock is $1.15, The gross proceeds of the public offering are expected to be approximately $3M before deducting agent placement fees and offering expenses. The closing of the public offering is expected to occur on or about February 5, subject to the satisfaction of customary closing conditions. Dawson James Securities is acting as the sole placement agent for the public offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GCTK:
- GlucoTrack Announces Reverse Stock Split and Clinical Study Success
- GlucoTrack announces completion of first in human clinical study of CGM
- GlucoTrack Inc trading halted, news pending
- Upcoming Stock Splits This Week (February 3 to February 7) – Stay Invested
- GlucoTrack Announces 1-for-20 Reverse Stock Split
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue